Hospital
South County Hospital Healthcare System
South County Hospital Healthcare System was paid $5.28M by Medicaid between Jan 2018 and Oct 2024, across 130 billing codes. Its largest line is 99284, emergency room visit (serious) — 15% of everything it billed.
33Billing provider infoSOUTH COUNTY HOSPITAL HEALTHCARE SYSTEM
WAKEFIELD, RI 02879
WAKEFIELD, RI 02879
33aNPI1952366106assigned 04/19/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$5.28M
24GClaims77,041
24DCodes billed130
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers
Next to other General Acute Care Hospital providers in Rhode Island
Rank by total paid#8 of 11
Median peer was paid$12.56M
This provider vs. median0.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 30,916 | $1.90M | |
| 2019 | 41,806 | $3.19M | |
| 2020 | 1,572 | $67K | |
| 2021 | 1,322 | $46K | |
| 2022 | 1,041 | $52K | |
| 2023 | 319 | $18K | |
| 2024incomplete | 65 | $4K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 15% | 1,929 | 1,572 | $772K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 8.9% | 1,374 | 1,164 | $470K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 7.6% | 903 | 743 | $402K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4.8% | 5,833 | 4,405 | $251K |
| 99218 | 3.7% | 252 | 186 | $198K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 3.6% | 2,818 | 2,069 | $191K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.2% | 1,041 | 838 | $171K |
| 36415 | Collection of venous blood by venipuncture | 2.6% | 6,799 | 5,463 | $139K |
| 80053 | Comprehensive metabolic panel | 2.2% | 3,238 | 2,507 | $115K |
| 59025 | Fetal non-stress test | 1.8% | 479 | 212 | $97K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.7% | 1,143 | 848 | $89K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.7% | 2,315 | 1,827 | $88K |
118 more codes
| 76830 | Ultrasound, transvaginal | 1.6% | 494 | $84K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.5% | 499 | $80K |
| 85027 | 1.5% | 2,294 | $78K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 1.5% | 419 | $77K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.3% | 494 | $71K |
| 71046 | Radiologic examination, chest; 2 views | 1.2% | 1,446 | $61K |
| 86317 | 1.2% | 1,400 | $61K | |
| 80061 | Lipid panel | 1.1% | 2,315 | $57K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1.0% | 986 | $54K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.0% | 179 | $53K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 594 | $51K |
| 83735 | <1% | 790 | $50K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 360 | $50K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 634 | $50K |
| 81001 | <1% | 1,431 | $49K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 262 | $46K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 360 | $45K |
| 80076 | <1% | 984 | $44K | |
| 84484 | <1% | 374 | $43K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 351 | $43K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,041 | $41K |
| 87081 | <1% | 1,787 | $40K | |
| 85610 | <1% | 1,218 | $38K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 416 | $35K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 294 | $35K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 200 | $33K |
| 88142 | <1% | 989 | $31K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 395 | $31K |
| 80306 | <1% | 440 | $31K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 767 | $28K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 764 | $28K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 59 | $28K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 180 | $27K |
| 87077 | <1% | 877 | $25K | |
| 82728 | <1% | 947 | $24K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 298 | $24K |
| 82607 | <1% | 860 | $24K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 83 | $23K |
| 86803 | <1% | 741 | $22K | |
| 81003 | <1% | 793 | $21K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,018 | $21K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 516 | $21K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 265 | $20K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 226 | $20K |
| 87186 | <1% | 636 | $19K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 452 | $18K |
| 84450 | <1% | 941 | $17K | |
| 85652 | <1% | 923 | $17K | |
| 83550 | <1% | 847 | $17K | |
| 83690 | <1% | 299 | $17K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 83 | $15K |
| 83540 | <1% | 877 | $14K | |
| 73630 | <1% | 205 | $14K | |
| 73562 | <1% | 118 | $14K | |
| 87088 | <1% | 539 | $13K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 99 | $13K |
| 82565 | <1% | 977 | $13K | |
| 86140 | <1% | 680 | $13K | |
| 86703 | <1% | 674 | $12K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 93 | $12K |
| 86901 | <1% | 281 | $11K | |
| 86850 | <1% | 286 | $11K | |
| 73610 | <1% | 128 | $11K | |
| 82550 | <1% | 237 | $11K | |
| 86900 | <1% | 276 | $11K | |
| 84460 | <1% | 772 | $10K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 30 | $9K |
| 87070 | <1% | 193 | $9K | |
| 84439 | <1% | 437 | $8K | |
| 82746 | <1% | 374 | $8K | |
| 93017 | <1% | 60 | $8K | |
| 84100 | <1% | 65 | $7K | |
| 84520 | <1% | 525 | $6K | |
| 83615 | <1% | 184 | $6K | |
| 87653 | <1% | 161 | $6K | |
| 85007 | <1% | 124 | $6K | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 115 | $6K |
| 80055 | <1% | 30 | $5K | |
| 80051 | <1% | 309 | $5K | |
| 87340 | <1% | 314 | $5K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 50 | $5K |
| 76813 | <1% | 34 | $4K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 148 | $4K |
| 72100 | <1% | 40 | $4K | |
| 76642 | <1% | 59 | $4K | |
| 82947 | <1% | 132 | $4K | |
| 87205 | <1% | 57 | $3K | |
| 85730 | <1% | 40 | $3K | |
| 86592 | <1% | 358 | $3K | |
| 84550 | <1% | 211 | $3K | |
| 86038 | <1% | 121 | $3K | |
| 71045 | Radiologic examination, chest; single view | <1% | 14 | $3K |
| 87075 | <1% | 15 | $3K | |
| 82310 | <1% | 209 | $3K | |
| 85379 | <1% | 15 | $2K | |
| 97803 | <1% | 16 | $2K | |
| 84153 | <1% | 78 | $2K | |
| 84481 | <1% | 96 | $2K | |
| 82950 | <1% | 179 | $2K | |
| 87480 | <1% | 65 | $2K | |
| 82043 | <1% | 152 | $2K | |
| 84436 | <1% | 49 | $2K | |
| 87660 | <1% | 52 | $2K | |
| 87510 | <1% | 52 | $2K | |
| 84702 | <1% | 54 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 37 | $1K |
| 86762 | <1% | 57 | $1K | |
| 82150 | <1% | 36 | $1K | |
| 73030 | <1% | 19 | $1K | |
| 82247 | <1% | 78 | $1K | |
| G0123 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision | <1% | 14 | $968.94 |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 32 | $800.61 |
| 82570 | <1% | 79 | $648.88 | |
| 73502 | <1% | 15 | $471.01 | |
| 84075 | <1% | 27 | $456.35 | |
| 86706 | <1% | 13 | $264.24 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 14 | $23.47 |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDESMARAIS, ELAINE (VP QUALITY & REGULATORY COMPLIANCE)